Skip to main content
Log in

Hepatitis B Virus Infection Predicts Extrahepatic Metastasis After Hepatic Resection in Patients With Large Hepatocellular Carcinoma

  • Hepatic and Pancreatic Tumors
  • Original Papers
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Although extrahepatic metastasis occurs rarely after hepatic resection for hepatocellular carcinoma (HCC), the prognosis of these patients is extremely poor. Predictors of extrahepatic metastasis have not been fully investigated.

Methods

To identify predictors of extrahepatic metastasis after resection, we retrospectively investigated 77 patients with HCC tumors >50 mm in diameter who underwent hepatic resection. We investigated correlations between postoperative extrahepatic metastasis and clinicopathologic factors as well as extrahepatic metastasis-free survival rate by log rank test and predictors of extrahepatic metastasis by univariate and multivariate logistic regression models.

Results

Hepatitis B surface antigen (HBs-Ag) was found in 25 (32.5%) of 77 patients, and extrahepatic metastasis occurred in 26 (33.8%). Patients with extrahepatic metastasis showed better liver function and a high occurrence of HBs-Ag positivity than those without. The 5-year extrahepatic metastasis-free survival rate was worse in patients with HBs-Ag positivity, larger tumors (≥70 mm), higher alfa-fetoprotein level (≥300 ng/mL), and lower indocyanine green retention rate at 15 minutes (ICGR15) (<15%) than in those without. By univariate logistic regression analysis, HBs-Ag positivity, larger HCC tumor (≥70 mm), lower ICGR15 (<15%), and lower preoperative lymphocyte count (<1000/mm3) were predictors of extrahepatic metastasis (P < .1). By multivariate analysis, HBs-Ag positivity was an independent predictor of postoperative extrahepatic metastasis (P = .04).

Conclusions

In patients positive for HBs-Ag, radiologic examination of extrahepatic organs should be performed as a part of the postoperative surveillance. Hepatitis B virus infection may promote establishment of extrahepatic metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

FIG. 1.

Similar content being viewed by others

References

  1. Sasaki A, Kai S, Iwashita Y, Hirano S, Ohta M, Kitano S. Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer 2005;103:299–306

    Article  PubMed  Google Scholar 

  2. Sasaki A, Iwashita Y, Shibata K, Matsumoto T, Ohta M, Kitano S. Improved long-term survival after liver resection for hepatocellular carcinoma in the modern era: a retrospective study from HCV-endemic areas. World J Surg 2006;30:1567–78

    Article  PubMed  Google Scholar 

  3. Hanazaki K, Kajikawa S, Shimozawa N, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg 2000;191:381–8

    Article  PubMed  CAS  Google Scholar 

  4. Jwo SC, Chiu JH, Chau GY, Loong CC, Lui WY. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 1992;16:1367–71

    Article  PubMed  CAS  Google Scholar 

  5. Sasaki A, Ishikawa K, Haraguchi N, et al. Receptor activator of nuclear factor-κ B ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis. Ann Surg Oncol 2007;14:1191–9

    Article  PubMed  Google Scholar 

  6. Poon RTP, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000;232:10–24

    Article  Google Scholar 

  7. Shimada M, Takenaka K, Gion T, et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996;111:720–6

    Article  PubMed  CAS  Google Scholar 

  8. Tomimaru Y, Sasaki Y, Yamada T, et al. The significance of surgical resection for pulmonary metastasis from hepatocellular carcinoma. Am J Surg 2006;192:46–51

    Article  PubMed  Google Scholar 

  9. Poon RT, Fan ST, O’Suilleabhain CB, Wong J. Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy. J Am Coll Surg 2002;195:311–8

    Article  PubMed  Google Scholar 

  10. Natsuizaka M, Omura T, Akaike T, et al. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol 2005;20:1781–7

    Article  PubMed  Google Scholar 

  11. Shuto T, Hirohashi K, Kubo S, et al. Distant metastatic recurrence after hepatic resection for hepatocellular carcinoma. Osaka City Med J 2002;48:17–21

    PubMed  Google Scholar 

  12. Si MS, Amersi F, Golish SR, et al. Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survival. Am Surg 2003;69:879–85

    PubMed  Google Scholar 

  13. Katyal S, Oliver JH 3rd, Peterson MS, Ferris JV, Carr BS, Baron RL. Extrahepatic metastases of hepatocellular carcinoma. Radiology 2000;216:698–703

    PubMed  CAS  Google Scholar 

  14. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907–17

    Article  PubMed  Google Scholar 

  15. Lara-Pezzi E, Majano PL, Yanez-Mo M, et al. Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix. J Hepatol 2001;34:409–15

    Article  PubMed  CAS  Google Scholar 

  16. Lara-Pezzi E, Serrador JM, Montoya MC, et al. The hepatitis B virus X protein (HBx) induces a migratory phenotype in a CD44-dependent manner: possible role of HBx in invasion and metastasis. Hepatology 2001;33:1270–81

    Article  PubMed  CAS  Google Scholar 

  17. Lee JO, Kwun HJ, Jung JK, Choi KH, Min do S, Jang KL. Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 2005;24:6617–25

    Article  PubMed  CAS  Google Scholar 

  18. Liver Cancer Study Group of Japan. Classification of Primary Liver Cancer. 2nd English edition. Tokyo: Kanehara, 2003

  19. Grazi GL, Ercolani G, Pierangeli F, et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 2001;234:71–8

    Article  PubMed  CAS  Google Scholar 

  20. Yamamoto J, Kosuge T, Takayama T, et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg 1996;83:1219–22

    Article  PubMed  CAS  Google Scholar 

  21. Lam CM, Lo CM, Yuen WK, Liu CL, Fan ST. Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg 1998;85:1198–200

    Article  PubMed  CAS  Google Scholar 

  22. Sakamoto Y, Kubota K, Mori M, et al. Surgical management for adrenal gland metastasis of hepatocellular carcinoma. Hepatogastroenterology 1999;46:1036–41

    PubMed  CAS  Google Scholar 

  23. Ogawa M, Yamamoto T, Kubo S, et al. Clinicopathologic analysis of risk factors for distant metastasis of hepatocellular carcinoma. Hepatol Res 2004;29:228–34

    Article  PubMed  Google Scholar 

  24. Utsunomiya T, Shimada M, Shirabe K, et al. Clinicopathological characteristics of patients with extrahepatic recurrence following a hepatectomy for hepatocellular carcinoma. Hepatogastroenterology 2001;48:1088–93

    PubMed  CAS  Google Scholar 

  25. Ganem D, Varmus HE. The molecular biology of the hepatitis B virus. Annu Rev Biochem 1987;56:651–93

    Article  PubMed  CAS  Google Scholar 

  26. Sasaki Y, Yamada T, Tanaka H, et al. Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B– or hepatitis C–related hepatocellular carcinoma. Ann Surg 2006;244:771–80

    Article  PubMed  Google Scholar 

  27. Bege T, Le Treut YP, Hardwigsen J, et al. Prognostic factors after resection for hepatocellular carcinoma in nonfibrotic or moderately fibrotic liver. A 116-case European series. J Gastrointest Surg 2007;11:619–25

    Article  PubMed  Google Scholar 

  28. Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991;351:317–20

    Article  PubMed  CAS  Google Scholar 

  29. Riesco A. Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils. Cancer 1970;25:135–40

    Article  PubMed  CAS  Google Scholar 

  30. Bruckner HW, Lavin PT, Plaxe SC, Storch JA, Livstone EM. Absolute granulocyte, lymphocyte, and monocyte counts: useful determinants of prognosis for patients with metastatic cancer of the stomach. JAMA 1982;247:1004–6

    Article  PubMed  CAS  Google Scholar 

  31. Elias EG, Leuchten JM, Buda BS, Brown SD. Prognostic value of initial mononucleated cell percentages in patients with epidermoid carcinoma of the head and neck. Am J Surg 1986;152:487–90

    Article  PubMed  CAS  Google Scholar 

  32. Sasaki A, Iwashita Y, Shibata K, Matsumoto T, Ohta M, Kitano S. Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma. Surgery 2006;139:755–64

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Atsushi Sasaki MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sasaki, A., Kai, S., Endo, Y. et al. Hepatitis B Virus Infection Predicts Extrahepatic Metastasis After Hepatic Resection in Patients With Large Hepatocellular Carcinoma. Ann Surg Oncol 14, 3181–3187 (2007). https://doi.org/10.1245/s10434-007-9570-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9570-x

Keywords

Navigation